The expression of FGF1 and FGF2 is induced in chronic liver diseases, and their expression levels are increased in more advanced tumor stages (Jin-no et al., 1997; Poon et al., 2001; Asada et al., 2003; Cheng et al., 2011; Sandhu et al., 2014). The gene discussed is FGF1; the disease is neoplasm.